A previous study using both techniques evaluating the pharmacokinetics of insulin preparations has indicated that artificially established non-physiological hyperinsulinemia interferes with the PK/PD parameters of insulin preparations (Liu et al., 2019). This evidence concerns the gene INS and Hyperinsulinemia.